| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 47.265 | 24.549 | 125.180 | 35.106 | 81.687 | 67.032 | 73.421 | 98.824 |
| Total Income - EUR | - | - | 47.272 | 24.577 | 125.332 | 35.136 | 81.704 | 67.063 | 73.471 | 110.494 |
| Total Expenses - EUR | - | - | 36.993 | 17.746 | 107.107 | 23.371 | 70.181 | 58.991 | 32.992 | 90.794 |
| Gross Profit/Loss - EUR | - | - | 10.278 | 6.832 | 18.224 | 11.765 | 11.523 | 8.072 | 40.478 | 19.700 |
| Net Profit/Loss - EUR | - | - | 8.861 | 6.095 | 14.469 | 10.723 | 9.367 | 6.322 | 34.280 | 15.736 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neuromedical Devices Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 11 | 0 | 14.053 | 10.110 | 6.291 | 2.704 | 0 | 30.633 |
| Current Assets | - | - | 17.920 | 16.179 | 25.695 | 27.421 | 66.021 | 34.985 | 78.150 | 50.575 |
| Inventories | - | - | 2.001 | 4.630 | 3.913 | 2.754 | 10.385 | 4.990 | 3.538 | 5.153 |
| Receivables | - | - | 3.283 | 2.917 | 11.692 | 3.083 | 9.399 | 5.978 | 45.840 | 4.491 |
| Cash | - | - | 12.636 | 8.631 | 10.090 | 21.584 | 46.237 | 24.017 | 28.771 | 40.930 |
| Shareholders Funds | - | - | 8.904 | 13.439 | 22.578 | 28.651 | 33.127 | 34.226 | 62.123 | 77.075 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 9.027 | 2.739 | 17.169 | 8.880 | 39.185 | 4.441 | 16.898 | 4.445 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Neuromedical Devices Srl